Regulatory T-Cell Generation and Kidney Allograft Tolerance Induced by Mesenchymal Stem Cells Associated With Indoleamine 2,3-Dioxygenase Expression

被引:280
|
作者
Ge, Wei
Jiang, Jifu
Arp, Jacqueline
Liu, Weihua [2 ]
Garcia, Bertha [2 ]
Wang, Hao [1 ,2 ,3 ]
机构
[1] Univ Western Ontario, Univ Hosp, London Hlth Sci Ctr, Multiorgan Transplant Program,Dept Surg, London, ON N6A 5A5, Canada
[2] Univ Western Ontario, Dept Pathol, London, ON N6A 5A5, Canada
[3] London Hlth Sci Ctr, Lawson Hlth Res Inst, London, ON, Canada
基金
加拿大创新基金会;
关键词
Tolerance; Regulatory T cells; Mesenchymal stem cells; Kidney transplantation; Indoleamine 2,3-dioxygenase; MARROW STROMAL CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PROLIFERATION IN-VITRO; VERSUS-HOST-DISEASE; BONE-MARROW; DENDRITIC CELLS; TRANSPLANT RECIPIENTS; GRAFT-SURVIVAL; INHIBIT; IMMUNOSUPPRESSION;
D O I
10.1097/TP.0b013e3181fed001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The immunoregulatory properties of mesenchymal stem cells (MSCs) have been observed in vitro and in vivo. However, the underlying mechanisms of this immunomodulation remain undefined. Recent research demonstrated that MSCs express the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO), known to suppress T-cell responses. This study was designed to address whether MSCs induce kidney allograft tolerance and whether IDO contributes to the immunoregulatory functions of MSCs in vivo. Methods. MSCs (1 x 10(6), intravenously) from wild-type (WT-MSCs) or IDO knockout (IDO-/--MSCs) C57BL/6 mice were injected into BALB/c recipients 24 hr after receiving a life-supporting orthotopic C57BL/6 renal graft. Results. WT-MSC-treated recipients achieved allograft tolerance with normal histology and undetectable antidonor antibody levels. Tolerant recipients demonstrated increased circulating kynurenine levels and significantly high frequencies of tolerogenic dendritic cells. They also exhibited significantly impaired CD4(+) T-cell responses consisting of decreased donor-specific proliferative ability and a Th2-dominant cytokine shift. In addition, high frequencies of CD4(+) CD25(+) Foxp3(+) regulatory T cells (Tregs) were found in recipient spleens and donor grafts, with antibody-induced CD25(+) cell depletion confirming the critical role of Tregs in the MSC-induced tolerance. Interestingly, renal allograft recipients treated with WT MSCs concomitant with the IDO inhibitor 1-methyl-tryptophan, or those treated with IDO-/--MSCs alone, were unable to achieve allograft tolerance-revealing that functional IDO was necessary for the immunosuppression observed with WT-MSC treatment. Conclusions. IDO secreted by MSCs was responsible, at least in part, for induction of kidney allograft tolerance through generation of Tregs. This study supports the clinical application of MSCs in transplantation.
引用
收藏
页码:1312 / 1320
页数:9
相关论文
共 50 条
  • [31] Indoleamine 2,3-dioxygenase in human hematopoietic stem cell transplantation
    Juergens, Birgit
    Hainz, Ursula
    Fuchs, Dietmar
    Heitger, Andreas
    AMINO ACIDS, 2009, 37 (01) : 89 - 90
  • [32] Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia
    Lucia Catani
    Daria Sollazzo
    Sara Trabanelli
    Antonio Curti
    Cecilia Evangelisti
    Nicola Polverelli
    Francesca Palandri
    Michele Baccarani
    Nicola Vianelli
    Roberto Massimo Lemoli
    Annals of Hematology, 2013, 92 : 67 - 78
  • [33] Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia
    Catani, Lucia
    Sollazzo, Daria
    Trabanelli, Sara
    Curti, Antonio
    Evangelisti, Cecilia
    Polverelli, Nicola
    Palandri, Francesca
    Baccarani, Michele
    Vianelli, Nicola
    Lemoli, Roberto Massimo
    ANNALS OF HEMATOLOGY, 2013, 92 (01) : 67 - 78
  • [34] Activation of the Regulatory T-Cell/Indoleamine 2,3-Dioxygenase Axis Reduces Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice
    Forteza, Maria J.
    Polyzos, Konstantinos A.
    Baumgartner, Roland
    Suur, Bianca E.
    Mussbacher, Marion
    Johansson, Daniel K.
    Hermansson, Andreas
    Hansson, Goran K.
    Ketelhuth, Daniel F. J.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [35] Potential regulatory function of dendritic cells overexpression indoleamine 2,3-dioxygenase
    Funeshima, N
    Fujino, M
    Kitazawa, Y
    Okuyama, T
    Li, XK
    MOLECULAR THERAPY, 2004, 9 : S248 - S248
  • [36] Immunosuppression by indoleamine 2,3-dioxygenase in mesenchymal stem cells derived from adult human tissues
    Lee, Myoung Woo
    Jang, In Keun
    Noh, Yoo Hun
    Kim, Dae Seong
    Kim, Hye Ryung
    Cheuh, Hee Won
    Lee, Soo Hyun
    Jung, Hye Urn
    Sung, Ki Woong
    Koo, Hong Hoe
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [37] Kidney Allograft Tolerance Induced by Soluble CD83 Monotherapy Associated with Prevalence of Tolerogenic Dendritic Cells and Expression of Indoleamine 2,3-Dioxygenase.
    Lan, Zhu
    Ge, Wei
    Arp, Jacqueline
    Jiang, Jifu
    Lian, Dameng
    Liu, Weihua
    Healey, Don
    Nicolette, Charles
    Jevnikar, Anthony
    Garcia, Bertha
    Wang, Hao
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 147 - 148
  • [38] FOXP3+Regulatory T Cells and Tumoral Indoleamine 2,3-Dioxygenase Expression Predicts the Carcinogenesis of the Pancreas
    Kobayashi, Noritoshi
    Kubota, Kensuke
    Shimamura, Takeshi
    Watanabe, Seitaro
    Kato, Shingo
    Nakajima, Atsushi
    GASTROENTEROLOGY, 2010, 138 (05) : S546 - S547
  • [39] Expression of indoleamine 2,3-dioxygenase (IDO) in multiple myeloma promotes the generation of regulatory T cells: Investigations into the role of hepatocyte growth factor
    Rutella, Sergio
    Bonanno, Giuseppina
    Corallo, Maria
    Mariotti, Andrea
    Procoli, Annabella
    Majolino, Ignazio
    De Cristofaro, Raimondo
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [40] IMMUNOGENIC CELL DEATH AND TOLERANCE INDUCTION: FOCUS ON INDOLEAMINE 2,3-DIOXYGENASE
    Ocadlikova, D.
    Lecciso, M. A.
    Trabanelli, S.
    Jandus, C.
    Romero, P.
    Sangaletti, S.
    Colombo, M.
    Orioli, E.
    De Marchi, E.
    Cavo, M.
    Di Virgilio, F.
    Adinolfi, E.
    Curti, A.
    HAEMATOLOGICA, 2016, 101 : S6 - S7